| Medicines Discovery Catapult (MDC). (8/11/22). "Press Release: Medicines Discovery Catapult and Zeiss Set Sights on Advancing Microscopy. Driving the Application of Microscopy in Drug Discovery". |
2022-08-11 |
| Evitria AG. (8/8/22). "Press Release: Genovis AB Enters Service Agreement with Evitria AG for Fast LC-MS Analysis of Recombinant Antibodies". |
2022-08-08 |
| Sartorius AG. (8/8/22). "Press Release: Sartorius to Acquire Albumedix, Strengthening Its Portfolio of Innovative Advanced Therapy Solutions". Göttingen. |
2022-08-08 |
| BioNTech SE. (8/5/22). "Press Release: BioNTech and Genmab Expand Global Strategic Collaboration to Develop and Commercialize Novel Immunotherapy Candidates". Mainz & Copenhagen. |
2022-08-05 |
| Poseida Therapeutics, Inc.. (8/3/22). "Press Release: Poseida Therapeutics Announces Strategic Global Collaboration with Roche Focused on Allogeneic CAR-T Cell Therapies for Hematologic Malignancies". San Diego, CA. |
2022-08-03 |
| Quantro Therapeutics GmbH. (8/3/22). "Press Release: Quantro Therapeutics Collaborates with Boehringer Ingelheim to Develop Drug Candidates Interfering with Transcriptional Regulators". Vienna. |
2022-08-03 |
| Formycon AG. (8/3/22). "Press Release: U.S. Food and Drug Administration (FDA) Approved FYB201/Cimerli (ranibizumab-eqrn), the First and Only Biosimilar Interchangeable with Lucentis". Munich, Amsterdam & Zug. |
2022-08-03 |
| ResMed Inc.. (8/2/22). "Press Release: ResMed Acquires Leipzig-based mementor with Insomnia Digital Health Solution somnio". Martinsried & Leipzig. |
2022-08-02 |
| NLC Ventures Netherlands B.V.. (8/2/22). "Press Release: Haermonics Series A Funding Offers Pure™ Promise for Future Heart Surgery Patients". Eindhoven. |
2022-08-02 |
| Eppendorf SE. (8/1/22). "Press Release: Eppendorf Opens New Site in Singapore". Singapore & Hamburg. |
2022-08-01 |
| Scienion GmbH. (7/28/22). "Press Release: Scienion Announces Expansion in the UK with the Opening of New R&D and Manufacturing Facilities". Lakeside North Harbour, Portsmouth. |
2022-07-28 |
| Cleerly, Inc.. (7/28/22). "Press Release: Heart Health Innovator Cleerly Closes Series C Funding Round with $223 Million [updated version of press release from 25 July]". New York, NY. |
2022-07-28 |
| Ginkgo Bioworks Inc.. (7/25/22). "Press Release: Ginkgo and Bayer Sign Definitive Agreement to Build Agricultural Biologicals R&D Platform Capabilities". Boston, MA. |
2022-07-25 |
| NeoSphere Biotechnologies GmbH. (7/25/22). "Press Release: NeoSphere Biotechnologies Closes Financing Round to Expand Proteomics Platform for Systematic Identification of Novel Targets for Targeted Protein Degradation". Munich. |
2022-07-25 |
| Sartorius AG. (7/21/22). "Press Release: Sartorius Remains on Growth Track. Figures for the First Half of 2022 – Sales Revenue up 20.9 Percent in Constant Currencies, Underlying
EBITDA up 25.6 Percent, Underlying EBITDA Margin 33.9 Percent". Göttingen. |
2022-07-21 |
| Sartorius Stedim Biotech S.A.. (7/21/22). "Press Release: Half-year Results 2022 of Sartorius Stedim Biotech. Sales Revenue up 22.1 Percent in Constant Currencies, Underlying EBITDA Margin 35.2 Percent
". Aubagne. |
2022-07-21 |
| Forty51 Ventures. (7/18/22). "Press Release: Forty51 Ventures Announces the First Close of Fund I and its First Investment". Luxembourg & Basel. |
2022-07-18 |
| Enterome S.A.. (7/18/22). "Press Release: Enterome Signs Major Strategic R&D Collaboration with Nestlé Health Science to Develop and Commercialize New AllerMimics and EndoMimics Immunotherapies for Food Allergies and Inflammatory Bowel Disease". Paris. |
2022-07-18 |
| Delfi Diagnostics, Inc.. (7/18/22). "Press Release: Delfi Diagnostics Announces $225 Million Series B Financing to Develop Globally Accessible Portfolio of Liquid Biopsy Tests". Baltimore, MD & Palo Alto, CA. |
2022-07-18 |
| SHS Gesellschaft für Beteiligungsmanagement mbH. (7/18/22). "Press Release: More than 220 Million Euros for Growth and Succession Investments in European Healthcare Companies". |
2022-07-18 |
| IZB Martinsried. (7/14/22). "Press Release: Cutting-edge Research at Munich’s IZB Attracts Strong Interest". Martinsried. |
2022-07-14 |
| Rubius Therapeutics, Inc.. (7/14/22). "Press Release: Rubius Therapeutics Appoints Susanne Schaffert, Ph.D., to its Board of Directors". Cambridge, MA. |
2022-07-14 |
| Heidelberg Pharma AG. (7/13/22). "Press Release: Heidelberg Pharma and Chiome Bioscience Sign Exclusive, Target-Specific Research and Option Agreement for the Development of an Antibody Drug Conjugate (ad hoc)". Ladenburg. |
2022-07-13 |
| Mosanna Therapeutics AG. (7/13/22). "Press Release: Mosanna Therapeutics Announces a Seed Financing Round to Advance Development of MOS-118 to Treat Metabolic Obstructive Sleep Apnea". Basel. |
2022-07-13 |
| BeiGene, Ltd.. (7/13/22). "Press Release: BeiGene Appoints Chan Lee as General Counsel". Cambridge, MA, Basel & Beijing. |
2022-07-13 |
| Corat Therapeutics GmbH. (7/13/22). "Press Release: € 38.7 Mio. German Government Funding for the Clinical Development of a Corona Medication". Braunschweig. |
2022-07-13 |
| Adrenomed AG. (7/12/22). "Press Release: Adrenomed Appoints David Germonpré as Chief Financial Officer". Zurich. |
2022-07-12 |
| Biosaxony. (7/12/22). "Pressemitteilung: Medical Forge Leipzig lässt die Funken fliegen". |
2022-07-12 |
| Delfi Diagnostics, Inc.. (7/12/22). "Press Release: Jessica Meng Joins Delfi Diagnostics as Chief Commercial Officer". Baltimore, MD. |
2022-07-12 |
| Anjarium Biosciences AG. (7/12/22). "Press Release: Anjarium Biosciences Appoints Experienced Industry Executives Samantha Vieira as Chief Operating Officer and Nate Massari as Chief Business Officer". Zurich. |
2022-07-12 |
| Solvias AG. (7/12/22). "Press Release: Solvias Acquires Cergentis to Bolster Biologics and Cell & Gene Therapy Capabilities". |
2022-07-12 |
| Vaccentis AG. (7/12/22). "Press Release: Vaccentis Appoints Martin Munte as CEO and Strengthens Board". Zurich. |
2022-07-12 |
| Glycomine, Inc.. (7/11/22). "Press Release: Glycomine Appoints Steven Axon as CEO and Adds Two New Board Directors". San Carlos, CA. |
2022-07-11 |
| ADC Therapeutics S.A.. (7/8/22). "Press Release: ADC Therapeutics Announces Exclusive License Agreement with Sobi to Develop and Commercialize Zynlonta (loncastuximab tesirine-lpyl) in Europe and Select International Territories". Lausanne. |
2022-07-08 |
| ECBF Management GmbH. (7/7/22). "Press Release: ECBF Expands Its Industrial Biotech Portfolio to Offer Naturally Produced Vitamins". Luxembourg. |
2022-07-07 |
| Immunic, Inc.. (7/6/22). "Press Release: Immunic, Inc. Strengthens Its Board of Directors with the Appointment of Maria Törnsén". New York, NY. |
2022-07-06 |
| BeiGene, Ltd.. (7/6/22). "Press Release: BeiGene Announces Strategic Research Collaboration with InnoRNA to Jointly Discover Novel mRNA Therapies". Cambride, MA, Basel & Beijing. |
2022-07-06 |
| Evotec SE. (7/6/22). "Press Release: Evotec, Boehringer Ingelheim, and bioMérieux Launch Aurobac, a Joint Venture to Fight Antimicrobial Resistance". Germany & France. |
2022-07-06 |
| Urovant Sciences. (7/5/22). "Press Release: Urovant Sciences and Pierre Fabre Médicament Enter into Exclusive License Agreement to Commercialize Vibegron for the Treatment of Overactive Bladder in the European Economic Area, UK, and Switzerland". Basel & |
2022-07-05 |
| CureVac N.V.. (7/5/22). "Press Release: CureVac Files Patent Infringement Lawsuit in Germany against BioNTech". Tübingen & Boston, MA. |
2022-07-05 |
| Evotec SE. (7/5/22). "Press Release: Evotec Completes Acquisition of Rigenerand". Hamburg. |
2022-07-05 |
| Scienion GmbH. (7/5/22). "Press Release: Highfield Diagnostics and Scienion Sign Memorandum of Understanding". Southampton & Berlin. |
2022-07-05 |
| Wacker Chemie AG. (7/5/22). "Press Release: Wacker to Start Construction of Competence Center for mRNA Actives at Halle Site". Tübingen & Boston, MA. |
2022-07-05 |
| Evotec SE. (7/4/22). "Press Release: Evotec SE – Translational BRIDGE Partnership beLAB2122 Selects Oncology Project from Goethe University Frankfurt". Hamburg. |
2022-07-04 |
| ADC Therapeutics S.A.. (7/1/22). "Press Release: ADC Therapeutics Appoints Jean-Pierre Bizzari, MD, to Board of Directors". Lausanne. |
2022-07-01 |
| Symrise AG. (6/30/22). "Press Release: Symrise Cosmetic Ingredients Enters Strategic Partnership with Evoxx Technologies". Holzminden. |
2022-06-30 |
| ADC Therapeutics S.A.. (6/29/22). "Press Release: ADC Therapeutics Doses First Patient in Phase 1b Clinical Trial of Zynlonta (loncastuximab tesirine-lpyl) in Combination with Other Anti-cancer Agents". Lausanne. |
2022-06-29 |
| BIO Deutschland e. V.. (6/29/22). "Press Release: President of German Biotechnology Industry Association Elected Chairman of International Umbrella Organization". Berlin. |
2022-06-29 |
| ReCode Therapeutics. (6/29/22). "Press Release: ReCode Therapeutics to Expand Next-Generation Delivery Platform and Diversify Genetic Medicines Pipeline with Oversubscribed Series B Financing Totaling $200M". Menlo Park, CA & Dallas, TX. |
2022-06-29 |
| Molzym GmbH & Co. KG. (6/29/22). "Press Release: Molzym Announces Double-Digit Million EUR Capital Increase". Bremen. |
2022-06-29 |
| mk2 Biotechnologies GmbH. (6/28/22). "Press Release: mk2 Biotechnologies and Sartorius Stedim Biotech Join Forces to Develop a Biologics Production Platform". |
2022-06-28 |
| VI Partners. (6/27/22). "Press Release: VI Partners Welcomes Simon Meier as Partner, Healthcare". |
2022-06-27 |
| Wacker Chemie AG. (6/2/22). "Press Release: Wacker to Invest Double-Digit Million-Euro Sum in Biotechnology Center". Munich. |
2022-06-27 |
| Verve Capital Partners AG (Verve Ventures). (6/24/22). "Press Release: Verve Ventures Launches Investment Fund to Support Portfolio Companies". |
2022-06-24 |
| Valneva S.E.. (6/24/22). "Press Release: Valneva Receives Marketing Authorization in Europe for Inactivated Whole-Virus COVID-19 Vaccine VLA2001". Saint-Herblain. |
2022-06-24 |
| Merck KGaA. (6/23/22). "Press Release: Merck Opens €59 Million CDMO Facility to Address Demand for Critical Cancer Therapies". Darmstadt. |
2022-06-23 |
| F-Star Therapeutics, Inc.. (6/23/22). "Press Release: invoX Pharma to Acquire F-star Therapeutics, Inc. a Pioneering Next Generation Bispecific Discovery Platform and Clinical Programs". London. |
2022-06-23 |
| Valneva S.E.. (6/23/22). "Press Release: Valneva and Pfizer Announce Closing of Equity Investment". Saint-Herblain & New York, NY. |
2022-06-23 |
| Ningaloo Biosystems GmbH. (6/22/22). "Press Release: Ningaloo’s Opto-Bioproduction Platform Gets Boost from Investors". Cologne. |
2022-06-22 |
| Tolremo Therapeutics AG. (6/22/22). "Press Release: Tolremo Therapeutics AG Announces Appointment of Dr. Karl Schumacher as Chief Medical Officer". Muttenz. |
2022-06-22 |
| Precision BioSciences Inc.. (6/21/22). "Press Release: Precision BioSciences Announces In Vivo Gene Editing Collaboration with Novartis to Develop Potentially Curative Treatment for Disorders Including Sickle Cell Disease". Durham, NC. |
2022-06-21 |
| Ascenion GmbH. (6/21/22). "Press Release: Carma Fund I Completes First Closing of EUR 47 Million to Accelerate the Transfer of Life-Science Research into Practice". Munich & Frankfurt a. M.. |
2022-06-21 |
| Knauer Wissenschaftliche Geräte GmbH. (6/21/22). "Press Release: Knauer Wissenschaftliche Geräte Is Partnering with ModuVision". |
2022-06-21 |
| Valneva S.E.. (6/20/22). "Press Release: Valneva and Pfizer Enter into an Equity Subscription Agreement and Update Terms of Collaboration Agreement for Lyme Disease Vaccine Candidate VLA15". Saint-Herblain & New York, NY. |
2022-06-20 |
| Kranus Health GmbH. (6/20/22). "Press Release: Kranus Health Closes Series A Financing and Has Now Raised a Total of 8 Million USD for Digital Men's Health". Berlin & München. |
2022-06-20 |
| Hong Kong Science and Technology Parks (HKSTP). (6/17/22). "Press Release: HKSTP and Boehringer Ingelheim Venture Fund Launch Co-Incubation Programme to Fast-track R&D in Infectious Diseases and Immunology". Hong Kong. |
2022-06-17 |
| Atai Life Sciences N.V.. (6/17/22). "Press Release: Stephen Bardin to Join Atai Life Sciences as CFO Designate". New York, NY & Berlin. |
2022-06-17 |
| Ymmunobio AG. (6/16/22). "Press Release: Ymmunobio Signs Collaboration Agreement with Yumab". Riehen. |
2022-06-16 |
| Gimv. (6/15/22). "Press Release: Gimv Strengthens Its Position in Life Sciences Venture Capital with the Creation of a New Dedicated Platform". Antwerp. |
2022-06-15 |
| HH2E AG. (6/15/22). "Press Release: HH2E and MET Group Establish a Joint Project Company to Develop One of Europe’s Largest Green Hydrogen Production Plants in Lubmin, Germany". |
2022-06-15 |
| MorphoSys AG. (6/14/22). "Press Release: MorphoSys and HIBio Enter Into Equity Participation and License Agreements for Felzartamab and MOR210". Planegg & South San Francisco, CA. |
2022-06-14 |
| Anjarium Biosciences AG. (6/14/22). "Press Release: Anjarium Biosciences Appoints Stephen Yoo, MD as Chief Executive Officer". Schlieren. |
2022-06-14 |
| Evotec SE. (6/14/22). "Press Release: Evotec Enters a Drug Discovery Collaboration with Janssen". Hamburg. |
2022-06-14 |
| ADC Therapeutics S.A.. (6/13/22). "Press Release: ADC Therapeutics Names David Gilman as Chief Business & Strategy Officer". Lausanne. |
2022-06-13 |
| ImCheck Therapeutics S.A.S.. (6/13/22). "Press Release: ImCheck Closes Upsized EUR 96 Million (USD 103 Million) Financing to Advance Clinical Program of First-in-human Gamma-delta T Cell Activating Antibody and Accelerate Development of Disruptive Immuno |
2022-06-13 |
| Bayer AG. (6/9/22). "Press Release: Bayer’s Vividion Emerging as Significant Player in San Diego Biotech Hub". Leverkusen & San Diego, CA. |
2022-06-09 |
| Pepperprint GmbH. (6/9/22). "Press Release: Pepperprint GmbH Introduces Novel Biomarker Set for Rheumatoid Arthritis Diagnosis at the 13th International Congress on Autoimmunity". Heidelberg. |
2022-06-09 |
| BIO Deutschland e. V.. (6/9/22). "Press Release: Biotechnology Sector Posts Record Turnover and R&D Investments". Berlin. |
2022-06-09 |
| Relation Therapeutics Ltd.. (6/9/22). "Press Release: Relation Therapeutics, the Active-Graph Machine Learning Drug Discovery Company, Names David Roblin as CEO and Lindsay Edwards as CTO". London. |
2022-06-09 |
| Forbion Capital Partners. (6/9/22). "Press Release: Forbion Announces First Close of Forbion Growth Opportunities Fund II at €470 Million". Naarden & Munich. |
2022-06-09 |
| Peptone Ltd.. (9/9/22). "Press Release: Peptone Closes a $40M Series-A Funding Round Led by F-Prime and Bessemer Venture Partners". London. |
2022-06-09 |
| BioVersys AG. (6/8/22). "Press Release: BioVersys AG Announces Successful First Closing of CHF 24.2 Million Series C Financing to Develop Clinical Pipeline of Novel AMR Therapies". Basel. |
2022-06-08 |
| Ariceum Therapeutics GmbH. (6/8/22). "Press Release: Ariceum Therapeutics Launches with EUR 25M Series A to Advance Lead Asset, Satoreotide, for the Treatment of Low- and High-Grade Neuroendocrine Cancers". Berlin. |
2022-06-08 |
| Bayer AG. (6/8/22). "Press Release: Bayer’s BlueRock Therapeutics Establishes European Site for Cell Therapy Innovation". Berlin. |
2022-06-08 |
| CureVac N.V.. (6/8/22). "Press Release: CureVac Accelerates Oncology Strategy with Acquisition of Frame Cancer Therapeutics, Adding Novel Antigen Discovery Platform". Tübingen & Amsterdam. |
2022-06-08 |
| ImmunOs Therapeutics AG. (6/7/22). "Press Release: ImmunOs Therapeutics Raises $74 Million Series B Financing Round". Schlieren & Gaithersburg, MD. |
2022-06-07 |
| High-Tech Gründerfonds Management GmbH. (6/7/22). "Press Release: Invasight Closes CHF 4.5 Million Oversubscribed Seed Round". Zurich. |
2022-06-07 |
| mk2 Biotechnologies GmbH. (6/7/22). "Press Release: mk2 Biotechnologies, Wacker and TUM Jointly Develop a Process for the Large-scale Production of Antimicrobial Peptides Based on Sustainable Fermentation". |
2022-06-07 |
| Upstream Bio (US). (6/2/22). "Press Release: Upstream Bio Launches with $200M Series A Financing to Advance Novel Therapeutics for Allergic and Inflammatory Diseases". Waltham, MA. |
2022-06-02 |
| Immatics N.V.. (6/2/22). "Press Release: Immatics and Bristol Myers Squibb Expand Strategic Alliance to Develop Gamma Delta Allogeneic Cell Therapy Programs". Tübingen, Houston, TX & New York, NY. |
2022-06-02 |
| Evonik Industries AG. (6/2/22). "Press Release: Evonik Invests US$220 Million in Partnership with the U.S. Government to Build New Lipid Production Facility for mRNA-based therapies in the U.S.". Essen & Parsipanny, NJ. |
2022-06-02 |
| Proxygen GmbH. (6/2/22). "Press Release: Proxygen Announces Strategic Collaboration with Merck to Develop Molecular Glue Degraders". Vienna. |
2022-06-02 |
| Immunic, Inc.. (6/2/22). "Press Release: Immunic, Inc. Reports Top-Line Data from Phase 2 CALDOSE-1 Trial of Vidofludimus Calcium in Patients with Moderate-to-Severe Ulcerative Colitis and Provides Corporate Update". New York, NY. |
2022-06-02 |
| DSM N.V.. (6/2/22). "Press Release: DSM and Firmenich to Merge, Becoming the Leading Creation and Innovation Partner in Nutrition, Beauty and Well-being [NOT FOR RELEASE WHERE VIOLATION OF LAW]". Vienna. |
2022-06-02 |
| BioInnovation Institute (BII). (6/2/22). "Press Release: High-quality Project from EMBL Is the First to Enter the Bio Studio Program". |
2022-06-02 |
| Scienion GmbH. (6/1/22). "Press Release: Scienion Appoints Frauke Hein as CEO". Berlin. |
2022-06-01 |
| Bayer AG. (5/31/22). "Press Release: BlueRock Therapeutics Announces Completion of Enrollment of Phase 1 Trial in Patients with Parkinson’s Disease". Cambridge, MA. |
2022-05-31 |
| BRAIN Biotech AG. (5/30/22). "Press Release: Prof. Dr. Bernhard Hauer Leaves Supervisory Board of BRAIN Biotech AG for personal reasons". Zwingenberg. |
2022-05-30 |
| BRAIN Biotech AG. (5/30/22). "Press Release: Ongoing Dynamic Sales Development and Rising Profitability, 6M Reporting". Zwingenberg. |
2022-05-30 |
| Evotec SE. (5/30/22). "Press Release: Evotec Adds Cell Therapy Manufacturing Facility with Acquisition of Rigenerand". Hamburg. |
2022-05-30 |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo-2019.png){kind=logo}
![Picture [iito] No Content Marketing 650x80px](/banner/iito-business-intelligence-20200507-650-080-summer-banner-series-no-content-marketing.jpg)
Date![Picture [iito] Fighting Customers 650x100px](/banner/iito-business-intelligence-20211013-650-100-summer-banner-series-fighting-customers.jpg)
![Picture [iito] [LSE] Life-Sciences-Europe.com Business Portal 650x300px](/banner/iito-business-intelligence-20220406-650-300-lse-life-sciences-europe.jpg)
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
